-+ 0.00%
-+ 0.00%
-+ 0.00%

Heron Therapeutics Affirms FY2025 Sales Guidance of $153.00M-$163.00M vs $157.27M Est

Benzinga·05/06/2025 12:09:22
Listen to the news
Heron Therapeutics (NASDAQ:HRTX) affirms FY2025 sales outlook from $153.00 million-$163.00 million to $153.00 million-$163.00 million vs $157.27 million estimate.